Colitis, Ulcerative clinical trials
The registry lists 1,485 studies for Colitis, Ulcerative across more than 10 countries. 398 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 665
- Recruiting
- 247
- Terminated
- 142
- Status unknown
- 138
- Not yet recruiting
- 123
- Active, not recruiting
- 90
Phase
- Phase 2
- 333
- Phase 3
- 211
- Phase 1
- 167
- Phase 4
- 106
- Early Phase 1
- 15
Where
- United States
- 509
- Canada
- 231
- Germany
- 216
- Poland
- 210
- France
- 204
- Italy
- 192
Who runs them
Takeda (45) · AbbVie (39) · Pfizer (32) · Janssen Research & Development, LLC (22) · Ferring Pharmaceuticals (18) · Assiut University (18) · Bristol-Myers Squibb (17) · Shire (16)
Studies
Recruiting first, then most recently updated. Showing 50 of 1,485 — search for more.
- FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled TrialNot yet recruitingNCT07576452Phase 41 country
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsRecruitingNCT06663332Phase 317 countries
- A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World SettingNot yet recruitingNCT07746765
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruitingNCT071023681 country
- A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)RecruitingNCT072422481 country
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisRecruitingNCT07697456Phase 22 countries
- Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseRecruitingNCT076195471 country
- A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative ColitisRecruitingNCT076063391 country
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07196748Phase 328 countries
- A Real-World Study of Guselkumab in Chinese Participants With Ulcerative ColitisRecruitingNCT073023601 country
- Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative ColitisNot yet recruitingNCT07502339Phase 41 country
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruitingNCT05076175Phase 2/313 countries
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruitingNCT06937086Phase 323 countries
- Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in BelgiumRecruitingNCT065810421 country
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 12 countries
- Immune Aging and Advanced Therapy Outcomes in Older Adults With IBDNot yet recruitingNCT07828886
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)RecruitingNCT04844606Phase 316 countries
- Phase 1b Clinical Study in Patients With Active Ulcerative ColitisNot yet recruitingNCT07834515Phase 1
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:RecruitingNCT07186101Phase 217 countries
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07415044Phase 228 countries
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseRecruitingNCT07483073Phase 210 countries
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisRecruitingNCT07071519Phase 315 countries
- Development of the SC-IBD Self-Care Measurement ScaleNot yet recruitingNCT074942271 country
- Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid TechnologyRecruitingNCT06805890Not applicable1 country
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)RecruitingNCT06095128Phase 42 countries
- Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)RecruitingNCT07513181Phase 21 country
- A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)RecruitingNCT07463183Phase 211 countries
- Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory Bowel DiseaseNot yet recruitingNCT07824726Not applicable1 country
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisRecruitingNCT06619990Phase 1/215 countries
- Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruitingNCT000011841 country
- The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited From Outpatient Clinic of Inflammatory Bowel Disease (IBD) of the National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, EgyptRecruitingNCT07758335Phase 41 country
- Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative ColitisNot yet recruitingNCT07820046Phase 2/3
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingRecruitingNCT06581328Phase 41 country
- Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative ColitisNot yet recruitingNCT07819799Phase 1
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07185009Phase 311 countries
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 218 countries
- Palmitoylethanolamide in Ulcerative ColitisRecruitingNCT07609810Not applicable1 country
- Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han DonorsRecruitingNCT07814456Phase 21 country
- Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel DiseaseNot yet recruitingNCT06510296Not applicable1 country
- Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)RecruitingNCT07582458Phase 2/31 country
- Conventional vs Biologic Therapy in Pediatric IBDNot yet recruitingNCT07818473
- Microbiome-targeted Diet Therapy in Ulcerative ColitisRecruitingNCT07520461Not applicable1 country
- Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in RemissionNot yet recruitingNCT07804511Not applicable1 country
- Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal InflammationRecruitingNCT07501078Phase 21 country
- Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisNot yet recruitingNCT07646223Phase 21 country
- E-nose in Evaluating Colitis ActivityNot yet recruitingNCT07781215
- Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm DevelopmentNot yet recruitingNCT078142741 country
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)RecruitingNCT06651281Phase 37 countries
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- IBD Strong Peer2Peer for Self-Management of Psychological DistressRecruitingNCT05722236Not applicable1 country